Beta Bionics (BBNX) Net Cash Flow (2024 - 2026)

Beta Bionics has disclosed Net Cash Flow across 3 years of filings, most recently posting -$1.4 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$1.4 million, down 111.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.2 million (down 160.09% YoY), and the FY2025 annual result was $1.1 million, down 70.41% from the prior year.
• Net Cash Flow came in at -$1.4 million for Q1 2026 at Beta Bionics, up from -$6.9 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $13.0 million in Q4 2024 to a low of -$9.0 million in Q2 2024.
• The 3-year median for Net Cash Flow is -$1.4 million (2026), against an average of $404444.4.
• Peak annual rise in Net Cash Flow reached 367.51% in 2025, while the deepest fall reached 153.35% in 2025.
• Beta Bionics' Net Cash Flow stood at $13.0 million in 2024, then slumped by 153.35% to -$6.9 million in 2025, then soared by 80.17% to -$1.4 million in 2026.
• The last three Net Cash Flow figures came in at -$1.4 million (Q1 2026), -$6.9 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.